Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
302,717,464
-
Number of holders
-
210
-
Total 13F shares, excl. options
-
225,422,707
-
Shares change
-
+2,514,573
-
Total reported value, excl. options
-
$1,027,886,640
-
Value change
-
-$73,855,004
-
Put/Call ratio
-
17.8%
-
Number of buys
-
114
-
Number of sells
-
-107
-
Price
-
$4.42
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q2 2022
277 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q2 2022.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 225,422,707 shares
of 302,717,464 outstanding shares and own 74.47% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (28,045,530 shares), Jackson Square Partners, LLC (22,762,042 shares), VANGUARD GROUP INC (21,241,318 shares), BlackRock Inc. (18,381,650 shares), Nikko Asset Management Americas, Inc. (14,345,485 shares), Sumitomo Mitsui Trust Holdings, Inc. (14,345,485 shares), Capital International Investors (11,575,496 shares), PRICE T ROWE ASSOCIATES INC /MD/ (10,284,090 shares), GOLDMAN SACHS GROUP INC (8,438,572 shares), and Bellevue Group AG (5,961,229 shares).
This table shows the top 210 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.